Zepbound (tirzepatide) and Wegovy (semaglutide) are two popular weight loss medications
There are a few factors that our physicians look for to determine whether a patient will be a good candidate for Semaglutide
5, TrumpRx.gov is officially live, with 40 drugs now available at discounted direct-to-consumer rates
Dextromethorphan, a key ingredient, exhibits psychoactive properties that lead to dependency
Real-world data from a 2025 study in Diabetes, Obesity and Metabolism which looked at actual clinical patients rather than trial participants showed tirzepatide patients lost 5.3% of body weight over six months compared to 2.7% with semaglutide
You should consider factors such as health conditions, weight loss goals, lifestyle, and preferences when it comes to choosing between them